Regulatory bodies across different countries are gradually shifting towards a more favorable stance for eConsent adoption. It allows trial participants to be provided with the information they need to make a decision at their own convenience – anywhere and anytime. However, regulations about the use of it can vary widely across borders. Get ready for potential regulatory changes that may affect the way you conduct research in 24 countries. This white paper covers the eConsent adoption landscape, country- specific legislation, and the practicalities of using eConsent in your clinical trial.
Countries covered:
- Australia
- Austria
- Belgium
- Brazil
- Canada
- China
- Denmark
- Finland
- France
- Germany
- India
- Ireland
- Israel
- Italy
- Japan
- Netherlands
- Poland
- Singapore
- South Korea
- Spain
- Sweden
- Switzerland
- United Kingdom
- United States